Literature DB >> 34242765

COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia.

Jad A Elharake1, Bayan Galal2, Saleh A Alqahtani3, Rana F Kattan4, Mazin A Barry5, Mohamad-Hani Temsah6, Amyn A Malik7, SarahAnn M McFadden8, Inci Yildirim9, Kaveh Khoshnood10, Saad B Omer11, Ziad A Memish12.   

Abstract

OBJECTIVES: The purpose of our study was to assess COVID-19 vaccine acceptance among health care workers (HCWs) in the Kingdom of Saudi Arabia (KSA) and identify: 1) vaccine acceptance barriers; 2) demographic differences; and 3) the most trusted COVID-19 sources of information.
METHODS: Between October and December 2020, all registered HCWs in the KSA were emailed a survey questionnaire, using Qualtrics® and Google Forms®, evaluating their acceptance of a COVID-19 vaccine.
RESULTS: Of the 23,582 participants surveyed, 15,299 (64.9%) said they would accept a COVID-19 vaccine. Vaccine acceptance among HCWs differed by several demographic characteristics, with males (69.7%), Christians (71.9%), and Pakistanis (81.6%) most likely to accept a COVID-19 vaccine. Of the 8,202 (35.1%) who said they would not accept a COVID-19 vaccine, the main reason reported was fear of potential side effects (58.5%). Participants reported health officials (84.6%) as the most reliable source of COVID-19 information. Additionally, participants reported the highest confidence in the KSA Ministry of Health (88.5%).
CONCLUSIONS: Overall, these findings provide KSA health care authorities with the information needed to develop public health messaging campaigns for HCWs to best address COVID-19 vaccine concerns-especially as the country prepares to vaccinate its general population.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  COVID-19; Kingdom of Saudi Arabia; health care workers; refusal; trust; vaccine acceptance

Mesh:

Substances:

Year:  2021        PMID: 34242765      PMCID: PMC8260488          DOI: 10.1016/j.ijid.2021.07.004

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


Introduction

Since the beginning of the coronavirus disease-2019 (COVID-19) pandemic, the Kingdom of Saudi Arabia (KSA) has reported approximately 383,000 and 6,600 COVID-19 cases and deaths, respectively (Our World in Data, 2021). In December 2020, the KSA began its COVID-19 vaccine rollout, becoming the first Arab country to distribute the Pfizer-BioNTech vaccine ("GCC News Roundup: Gulf states roll out COVID-19 vaccination campaigns, Saudi Arabia faces financial woes (December 1-31)," 2021). Since then, the first phase of vaccine distribution has included first-responders and health care workers (HCWs) (Reuters, 2020). Given that new virus strains have arisen and vaccines with lower efficacy rates have also been distributed, higher vaccination rates will be needed to achieve herd immunity (Achenbach & Eunjung Cha, 2021). Therefore, there is an even greater need to assess the factors impacting vaccine uptake among HCWs. However, underlying trust issues and the spread of misinformation about COVID-19 may affect vaccine uptake. Recently, a survey sent to the KSA general population found that most KSA adults reported false information about the COVID-19 pandemic and vaccines (e.g., flu and pneumonia vaccines protect against COVID-19) (Baig et al., 2020). Given that misinformation can have severe implications for worsening the spread of the virus and potentially reducing vaccine acceptance, HCWs play an essential role in being a source of trusted medical information for the KSA general public (Alduraywish et al., 2020). While there are data on COVID-19 vaccine sentiments expressed by the general population (Al-Mohaithef & Padhi, 2020), assessing the attitudes of HCWs and their potential to impact the general public's opinion is also essential. It was recently reported that 30% of the KSA HCW population were unwilling to receive a COVID-19 vaccine (Barry et al., 2020). However, little is known about the factors associated with COVID-19 vaccine refusal. The high vaccination rates needed to contain the virus can potentially be better achieved by understanding HCWs’ perceptions of the COVID-19 vaccine. Thus, the purpose of our study was to describe the current COVID-19 vaccine acceptance landscape among HCWs in the KSA with aims to identify: 1) COVID-19 vaccine acceptance barriers; 2) demographic differences in COVID-19 vaccine refusal, and 3) the most trusted COVID-19 sources of information and organizations. Our findings will provide KSA health care authorities with an understanding of the COVID-19 vaccine acceptance among the HCW population, especially as the country plans to vaccinate its general population, which may help frame messaging and improve overall acceptance and uptake.

Methods

Data were collected between October and December 2020, using an electronic questionnaire via Qualtrics® (Qualtrics, Provo, UT) and Google Form® (Google, Mountainview, CA). Using purposive sampling, the survey (Supplementary Material) was emailed by the Saudi Commission for Health Specialties (SCHS), with the option to choose English or Arabic, to HCWs who were registered with the SCHS. The SCHS is a group of approximately 700,000 HCWs (including physicians, nurses, and physician assistants) who supervise and evaluate training programs and set standards for health care practice at all levels in the KSA (Saudi Commission for Health Specialties, 2021). Participants were eligible if they were 18 years of age or older, a HCW, could read English and/or Arabic, and had access to the internet via computer and/or smartphone. The survey was adapted from a previous study (Malik, McFadden, Elharake, & Omer, 2020) and contained 22 questions that required a response and one optional question that did not require a response from the participants. Basic demographic information was collected, as well as the country of origin and religious affiliation. Additionally, we asked participants the following question: “If a vaccine for COVID-19 becomes available in your country and is recommended for you, will you take it?”; this variable was dichotomized to COVID-19 vaccine acceptance (0 = No/Don't know; 1 = Yes). Participants who responded “No” or “Don't know” were then asked for the main reason for not accepting a COVID-19 vaccine with the following choices: 1) religion; 2) fear of potential side effects; 3) lack of trust for those creating and distributing the vaccine, and 4) do not believe vaccines work. This was the one optional question that did not require a response. Finally, participants were asked about their confidence in media sources and the reliability of these sources regarding the COVID-19 pandemic; these variables were dichotomized (0 = Very Little/Little/Some/Don't Know; 1 = Much/Very Much). The Yale University Institutional Review Board (IRB protocol number: 2000029237) and the KSA Ministry of Health (MOH; H-01-R-053) approved this study. Participants provided e-consent before data collection.

Statistical Analysis

Survey results were summarized, graphed, analyzed, and reported using Microsoft Excel® (Microsoft, Redmond, WA) and STATA® (STATA, Version 16.1, College Station, TX). Descriptive statistics were used to determine the sample demographic characteristics. Additionally, the frequency and percentage of responses to questions pertaining to COVID-19 vaccine acceptance, reasons for not accepting a COVID-19 vaccine, and confidence in organizations, and reliability of media sources regarding COVID-19 were calculated. Lastly, univariable and multivariable logistic regressions were used to assess the associations between demographic factors with COVID-19 vaccine acceptance. The multivariable model was adjusted for potential confounders, including age, gender, country of origin, religion, and education. The results were reported as the odds ratios (ORs) with 95 confidence intervals (95% CI). Two-sided p-values <0.05 were considered statistically significant.

Results

A total of 23,582 participants completed the survey with 12,365 (52.4%) males, 10,917 (46.3%) were 25-34 years old, and 12,208 (51.7%) had a graduate/professional degree. Most of the participants reported their country of origin as KSA (n = 12,630; 53.6%) and identified as Muslim (n = 18,787; 79.7%). Table 1 shows the characteristics of the survey participants and the KSA HCW population.
Table 1

Demographic Characteristics & COVID-19 Vaccine Acceptance among HCWs in KSA (N = 23,582)

n (%)*COVID-19 Vaccine Acceptance (Total = 15,299/23,582; 64.9%) n (%)⁎⁎
Gender
 Male12,365 (52.4)8,619 (69.7)
 Female11,217 (47.6)6,680 (59.6)
Age (years)
 18-24669 (2.9)442 (66.1)
 25-3410,917 (46.3)7,156 (65.6)
 35-447,693 (32.6)4,866 (63.3)
 45-543,164 (13.4)2,065 (65.3)
 55+1,139 (4.8)770 (67.6)
Country of Origin
 Egypt2,256 (9.6)1,730 (76.7)
 India1,500 (6.4)1,219 (81.3)
 Jordan307 (1.3)173 (56.4)
 Lebanon81 (0.3)41 (50.6)
 Malaysia200 (0.8)158 (79.0)
 Pakistan523 (2.2)427 (81.6)
 Philippines3,762 (15.9)2,692 (71.6)
 Saudi Arabia12,630 (53.6)7,373 (58.4)
 Sudan819 (3.5)556 (67.9)
 Syria401 (1.7)274 (68.3)
 Other1,103 (4.7)656 (59.5)
Religion
 Christianity4,208 (17.8)3,025 (71.9)
 Islam18,787 (79.7)11,838 (63.0)
 None125 (0.5)69 (55.2)
 Other462 (2)367 (79.4)
Education
 No High School41 (0.2)30 (73.2)
 High School509 (2.1)323 (63.5)
 Some College1,343 (5.7)840 (62.6)
 College9,481 (40.2)5,883 (62.1)
 Graduate/Professional12,208 (51.8)8,223 (67.4)
Chronic Illness
 Yes3,432 (14.6)2,203 (64.2)
 No20,150 (85.4)13,096 (65.0)
Have been sick with COVID-19
 Yes3,481 (14.8)2,266 (65.1)
 No20,101 (85.2)13,033 (64.8)
Know someone who has been sick with COVID-19
 Yes16,219 (68.8)10,370 (63.9)
 No7,363 (31.2)4,929 (66.9)

Denominator is the total sample size = 23,582.

Denominator is the number of participants per demographic characteristic.

Demographic Characteristics & COVID-19 Vaccine Acceptance among HCWs in KSA (N = 23,582) Denominator is the total sample size = 23,582. Denominator is the number of participants per demographic characteristic.

COVID-19 Vaccine Acceptance

Of the 23,582 participants surveyed, 15,299 (64.9%) said they would accept a COVID-19 vaccine (Table 1). Vaccine acceptance among the health care population differed by several demographic characteristics. Males (8,619/12,365; 69.7%), Christians (3,025/4,208; 71.9%), and Pakistanis (427/523; 81.6%) comprised the largest groups of respondents who were most likely to accept a COVID-19 vaccine (Table 1). A multivariable logistic regression analysis (Table 2 ) showed that after adjusting for gender, age, country of origin, religion, education, chronic illness, have been sick with COVID-19, and known someone who has been sick with COVID-19, HCWs in the KSA who were female (OR: 0.5; 95% CI: 0.5 – 0.6; p < 0.001) were less likely to accept a COVID-19 vaccine compared to males. Those who were 35-44 years old (OR: 0.8; 95% CI: 0.7 – 0.8; p < 0.001), 45-54 years old (OR: 0.8; 95% CI: 0.7 – 0.8; p < 0.001), and 55 years and older (OR: 0.8; 95% CI: 0.7 – 0.9; p < 0.01) were also less likely to accept a COVID-19 vaccine compared to those 25-34 years old. Additionally, most non-Saudi participants were more likely to accept a COVID-19 vaccine than those from the KSA (see Table 2 for more details). Those who reported their level of education as high school (OR: 1.3; 95% CI: 1.0 – 1.5; p = 0.02), some college (OR: 1.3; 95% CI: 1.1 – 1.4; p < 0.001), or college (OR: 1.2; 95% CI: 1.1 – 1.2; p < 0.001) were more likely to accept a COVID-19 vaccine compared with those with a graduate/professional degree. Lastly, those who did not know someone who contracted COVID-19 were more likely to accept a COVID-19 vaccine than those who did (OR: 1.1; 95% CI: 1.0 – 1.2; p = 0.01).
Table 2

Multivariable Ordinal Logistic Regression of COVID-19 Vaccine Acceptance across Demographic Characteristics

Unadjusted
Adjusted
VariableORp-value95% CIORp-value95% CI
Outcome: COVID-19 Vaccine Acceptance
Gender
 MaleRef
 Female0.6<0.0010.6 - 0.70.5<0.0010.5 - 0.6
Age (years)
 25-34Ref
 18-2410.80.9 - 1.21.4<0.0011.2 - 1.7
 35-440.9<0.010.9 - 1.00.8<0.0010.7 - 0.8
 45-5410.80.9 - 1.10.8<0.0010.7 - 0.8
 55+1.10.21.0 - 1.20.8<0.010.7 - 0.9
Country of Origin
Saudi ArabiaRef
 Egypt2.3<0.0012.1 - 2.62.4<0.0012.2 - 2.7
 India3.1<0.0012.7 - 3.53.9<0.0013.3 - 4.6
 Jordan0.90.50.7 - 1.210.70.8 - 1.2
 Lebanon0.70.20.5 - 1.10.90.50.6 - 1.3
 Malaysia2.7<0.0011.9 - 3.84.3<0.0013.0 - 6.0
 Pakistan3.2<0.0012.5 - 4.03.6<0.0012.9 - 4.6
 Philippines1.8<0.0011.7 - 1.92.5<0.0012.2 - 2.9
 Sudan1.5<0.0011.3 - 1.81.7<0.0011.4 - 2.0
 Syria1.5<0.0011.2 - 1.91.6<0.0011.3 - 1.9
 Other10.50.9 - 1.21.2<0.011.1 - 1.4
Religion
 IslamRef
 Christianity1.5<0.0011.4 - 1.61.10.40.9 - 1.2
 None0.70.10.5 - 1.00.80.10.5 - 1.1
 Other2.3<0.0011.8 - 2.81.30.11.0 - 1.6
Education
 Graduate/ProfessionalRef
 No High School1.30.40.7 - 2.61.80.10.9 - 3.7
 High School0.80.10.7 - 1.01.30.021.0 - 1.5
 Some College0.8<0.0010.7 - 0.91.3<0.0011.1 - 1.4
 College0.8<0.0010.7 - 0.81.2<0.0011.1 - 1.2
Chronic Illness
 NoRef
 Yes1.00.40.9 – 1.01.10.21.0 – 1.1
Have been sick with COVID-19
 NoRef
 Yes1.00.80.9 – 1.11.00.90.9 – 1.1
Know someone who has been sick with COVID-19
 YesRef
 No1.1<0.0011.1 – 1.21.10.011.0 – 1.2
Multivariable Ordinal Logistic Regression of COVID-19 Vaccine Acceptance across Demographic Characteristics

Reasons for Refusal to Accept COVID-19 Vaccines

Of the 8,202 (35.1%) who said they would not accept a COVID-19 vaccine, 4,801 (58.5%) reported fear of potential side effects, 2,827 (34.5%) reported lack of trust for those creating and distributing the vaccine, 541 (6.6%) reported they do not believe vaccines work, and 33 (0.4%) reported religion (Figure 1 ).
Figure 1

Reasons for COVID-19 Vaccine Refusal among HCWs in the KSA (N = 8,202*)

*Legend: missing data (n = 81)

Reasons for COVID-19 Vaccine Refusal among HCWs in the KSA (N = 8,202*) *Legend: missing data (n = 81) Across demographic groups, the two most common reasons participants reported for not accepting a COVID-19 vaccine were fear of potential side effects and lack of trust for those creating and distributing the vaccine. See Table 3 for more details.
Table 3

Reasons for COVID-19 Vaccine Refusal across Demographic Characteristics

Total N = 23,582; n (%)*Would not accept a COVID-19 Vaccine if it is recommended to them; Total N = 8,202; n (%)⁎⁎Religion n (%)⁎⁎⁎Fear of potential side effects n (%)⁎⁎⁎Lack of trust for those creating and distributing the vaccine n (%)⁎⁎⁎Do not believe vaccines work n (%)⁎⁎⁎
Gender
 Male12,365 (52.4)3706 (30.0)20 (0.5)1,963 (53.0)1,490 (40.2)233 (6.3)
 Female11,217 (47.6)4496 (40.1)13 (0.3)2,838 (63.1)1,337 (29.7)308 (6.9)
Age (years)
 18-24669 (2.9)223 (33.3)1 (0.5)129 (57.9)74 (33.2)19 (8.5)
 25-3410,917 (46.3)3714 (34.0)12 (0.3)2,276 (61.3)1,191 (32.1)235 (6.3)
 35-447,693 (32.6)2808 (36.5)15 (0.5)1,598 (56.9)997 (35.5)198 (7.1)
 45-543,164 (13.4)1090 (34.5)5 (0.5)615 (56.4)401 (36.8)69 (6.3)
 55+1,139 (4.8)367 (32.2)0 (0)183 (49.9)164 (44.7)20 (5.5)
Country of Origin
 Egypt2,256 (9.6)520 (23.0)0 (0)314 (60.4)188 (36.2)18 (3.5)
 India1,500 (6.4)263 (17.5)2 (0.8)162 (61.6)61 (23.2)38 (14.5)
 Jordan307 (1.3)131 (42.7)1 (0.8)63 (48.1)60 (45.8)7 (5.3)
 Lebanon81 (0.3)40 (49.4)0 (0)18 (45)19 (47.5)3 (7.5)
 Malaysia200 (0.8)42 (21)0 (0)23 (54.8)16 (38.1)3 (7.1)
 Pakistan523 (2.2)95 (18.2)0 (0)51 (53.7)36 (37.9)8 (8.4)
 Philippines3,762 (15.9)1066 (28.3)5 (0.5)910 (85.4)124 (11.6)27 (2.5)
 Saudi Arabia12,630 (53.6)5214 (41.3)22 (0.4)2,835 (54.4)1,962 (37.6)395 (7.6)
 Sudan819 (3.5)259 (31.6)0 (0)128 (49.4)120 (46.3)11 (4.3)
 Syria401 (1.7)127 (31.7)0 (0)74 (58.3)52 (40.9)1 (0.8)
 Other1,103 (4.7)445 (40.3)3 (0.7)223 (50.1)189 (42.5)30 (6.7)
Religion
 Christianity4,208 (17.8)1168 (27.8)7 (0.6)899 (77.0)214 (18.3)48 (4.1)
 Islam18,787 (79.7)6886 (36.7)25 (0.4)3,824 (55.5)2,563 (37.2)474 (6.9)
 None125 (0.5)56 (44.8)0 (0)18 (32.1)29 (51.8)9 (16.1)
 Other462 (2)92 (19.9)1 (1.1)60 (65.2)21 (22.8)10 (10.9)
Education
 No High School41 (0.2)11 (26.8)0 (0)8 (72.7)2 (18.2)1 (9.1)
 High School509 (2.1)185 (36.3)5 (2.7)118 (63.8)48 (26.0)14 (7.6)
 Some College1,343 (5.7)497 (37)4 (0.8)273 (54.9)170 (34.2)50 (10.1)
 College9,481 (40.2)3559 (37.5)12 (0.3)2,037 (57.2)1,243 (34.9)267 (7.5)
 Graduate/Professional12,208 (51.8)3950 (32.4)12 (0.3)2,365 (59.9)1,364 (34.5)209 (5.3)
Chronic Illness
 Yes3,432 (14.6)1222 (35.6)4 (0.3)698 (57.1)454 (37.2)66 (5.4)
 No20,150 (85.4)6980 (34.6)29 (0.4)4,103 (58.8)2,373 (34.0)475 (6.8)
Have been sick with COVID-19
 Yes3,481 (14.8)1198 (34.4)2 (0.2)684 (57.1)425 (35.5)87 (7.3)
 No20,101 (85.2)7004 (34.8)31 (0.4)4,117 (58.8)2,402 (34.3)454 (6.5)
Know someone who has been sick with COVID-19
 Yes16,219 (68.8)5788 (35.7)17 (0.3)3,357 (58.0)2,047 (35.4)367 (6.3)
 No7,363 (31.2)2414 (32.8)16 (0.7)1,444 (59.8)780 (32.3)174 (7.2)

Denominator is the total sample size = 23,582.

Denominator is the number of participants per demographic characteristic.

Denominator is the number of participants per demographic characteristic for those who would not accept a COVID-19 vaccination.

Reasons for COVID-19 Vaccine Refusal across Demographic Characteristics Denominator is the total sample size = 23,582. Denominator is the number of participants per demographic characteristic. Denominator is the number of participants per demographic characteristic for those who would not accept a COVID-19 vaccination.

COVID-19 Reliability of Media Sources and Confidence in Organizations

Participants reported health officials (n = 19,949; 84.6%), health care providers (n = 19,159; 81.2%), and the World Health Organization (WHO) (n = 14,793; 62.7%) as the most reliable media sources of COVID-19 information (Figure 2 ). Additionally, participants reported the highest confidence in the KSA MoH (n = 20,872; 88.5%), the KSA Government (n = 20,568; 87.2%), health care providers (n = 19,956; 84.6%), and the WHO (n = 14,588; 61.9%) (Figure 3 ).
Figure 2

Reliability of COVID-19 Sources of Information across COVID-19 Vaccine Landscape

Figure 3

Confidence in KSA Organizations across COVID-19 Vaccine Landscape

Reliability of COVID-19 Sources of Information across COVID-19 Vaccine Landscape Confidence in KSA Organizations across COVID-19 Vaccine Landscape

COVID-19 Reliability of Media Sources and Confidence in Organizations across the COVID-19 Vaccine Landscape

Participants who would take the COVID-19 vaccine (n = 15,299; 64.9%) reported health officials (n = 13,580; 88.8%), health care providers (n = 13,042; 85.3%), the WHO (n = 10,687; 69.9%), and websites (n = 9,037; 59.1%) as the most reliable media sources of COVID-19 information (Figure 2). Participants who would not take the COVID-19 vaccine (n = 8,202; 35.1%) reported health officials (n = 6,369; 76.9%) and health care providers (n = 6,117; 73.9%) as the most media reliable sources of COVID-19 information (Figure 2). Additionally, participants who would take the COVID-19 vaccine (n = 15,299; 64.9%) reported the highest confidence in the KSA MoH (n = 14,169; 92.6%), the KSA Government (n = 13,858; 90.6%), health care providers (n = 13,591; 88.8%), and the WHO (n = 10,626; 69.5%) (Figure 3). Participants who would not take the COVID-19 vaccine (n = 8,202; 35.1%) reported the highest confidence in the KSA MoH (n = 6,703; 80.9%), the KSA Government (n = 6,710; 81.0%), and health care providers (n = 6,365; 76.8%) (Figure 3).

Discussion

We found a majority of KSA HCWs (64.9%) would accept a COVID-19 vaccine. Among those who would not accept a COVID-19 vaccine, the main reason reported for vaccine refusal was fear of potential side effects. Additionally, participants reported health officials and health care providers as the most reliable media sources of COVID-19 information. Across KSA organizations, HCWs reported the highest confidence in the KSA MoH, the KSA Government, and health care providers. Overall, these findings provide KSA health care authorities with the information needed to develop COVID-19 messaging campaigns to best address COVID-19 vaccine concerns—especially as the country prepares to vaccinate its general population. The KSA MoH has now approved three COVID-19 vaccines (Pfizer/BioNTech, AstraZeneca, and Moderna) to be distributed from over 100 vaccination facilities across the country (Ministry of Health, 2021). However, immunization programs are only successful when there are high rates of acceptance and coverage. While most of the KSA HCWs in our study would accept a COVID-19 vaccine, this level of acceptance (64.9%) may not be sufficient to reach the herd immunity threshold, which is estimated to be between 55% and 82% (Sanche et al., 2020). Additionally, COVID-19 vaccine acceptance rates among HCWs in other countries are significantly higher, such as Canada (70.4%), France (75.4%), Belgium (76.0%), China (76.4%), United States (92.0%), and Indonesia (95.5%) (Fu et al., 2020; Harapan et al., 2020; Shekhar et al., 2021; Verger et al., 2021). However, we acknowledge that reported acceptance may not always translate into actual behavior. For example, only one-third of the KSA HCW population has enrolled to receive or has already received a COVID-19 vaccine (Barry et al., 2021). Given the alarming gap between our study's 64.9% vaccine acceptance and the current reported vaccine coverage of 33.3% (Barry et al., 2021), KSA health care authorities should swiftly launch vaccine messaging and educational campaigns catered to HCWs to improve uptake in a COVID-19 vaccine. Given that our study found demographic differences in COVID-19 vaccine acceptance, message-framing to encourage trust in a COVID-19 vaccine must also be catered to specific demographic groups across the HCW population. Female HCWs were less likely to accept a COVID-19 vaccine compared to males, which was consistent with a previous influenza vaccine acceptance study (Alshammari, Yusuff, Aziz, & Subaie, 2019) and other KSA COVID-19 vaccine acceptance studies (Barry et al., 2020; Barry et al., 2021; Magadmi & Kamel, 2020). The gender difference in COVID-19 vaccine acceptance may be due to the WHO and KSA MoH recommending pregnant women not to take the COVID-19 vaccine due to the lack of data on the effects of a COVID-19 vaccine on the risks of pregnancy (Gulf Insider Report, 2021; World Health Organization, 2021b). Additionally, males may be more likely to accept a COVID-19 vaccine due to the several studies that have reported higher risks for COVID-19 hospitalization, infection, and death among males (Chen et al., 2020; Galbadage et al., 2020; Peckham et al., 2020). Health care authorities must clarify any confusion regarding COVID-19 vaccine information among female HCWs to increase vaccine uptake. Our study also found that health care workers between 25-34 years of age were more likely to accept a COVID-19 vaccine than those who were 35-44, 45-54, and 55 years and older. While this finding was consistent with a previous study evaluating the general KSA population (Magadmi & Kamel, 2020), it is contrary to other KSA studies (Al-Mohaithef & Padhi, 2020; Barry et al., 2021). One possible explanation for why younger HCWs were more likely to accept a COVID-19 vaccine than older HCWs may be due to the social restrictions and curfews that were enforced by KSA authorities. Although these mitigations were enacted to reduce the spread of the virus, it may have impacted the younger population more, which is why they may have been more willing to receive the vaccine. Additionally, HCWs who reported their level of education as high school, some college, or college were more likely to accept a COVID-19 vaccine than those with a graduate/professional degree. While our finding differs from that of previous COVID-19 vaccine acceptance studies (Al-Mohaithef & Padhi, 2020; Magadmi & Kamel, 2020), HCWs with lower educational degrees may be more likely to accept a COVID-19 vaccine because they are less likely to provide telecommuting health care services compared to HCWs who are physicians. Given that their jobs require more frequent in-person contact with patients, which will increase their risk of contracting COVID-19, these HCWs may be more likely to accept a COVID-19 vaccine than physicians who have the option to work from home. Across the respondents who would not accept a COVID-19 vaccine, the most common reported reason for their refusal was fear of potential side effects. COVID-19 vaccine hesitancy studies worldwide have identified similar concerns among HCWs and the general population (Chou & Budenz, 2020; Dror et al., 2020; Khan et al., 2020; Murphy et al., 2021). COVID-19 vaccines were rapidly developed in less than a year, so HCWs may be hesitant to accept the vaccine, given that previous vaccines have taken 10-15 years to produce (History of Vaccines, 2021). However, researchers were already familiar with coronaviruses, including SARS and MERS, and this existing data helped speed up the vaccine development process. Additionally, given that the spread of COVID-19 led to a pandemic that detrimentally impacted the social, economic, and employment realms, international organizations (e.g., the US Operation Warp Speed, the European Commission, and the UK Government Vaccine Taskforce.) invested millions of dollars for vaccine researchers to mobilize quickly (World Health Organization, 2021a). Therefore, health care authorities in the KSA must address any misinformation about COVID-19 side effects to improve uptake among HCWs. In our study, HCWs reported health officials and health care providers as the most reliable COVID-19 media sources of information. Among KSA organizations, participants reported the highest confidence in the KSA MoH, the KSA Government, and health care providers. These findings highlight the need for COVID-19 vaccine messaging to be mainly communicated by health officials and health care providers through the KSA MoH and Government. HCWs also play a crucial role in being one of the most trusted sources of medical information for the general public in the KSA (Alduraywish et al., 2020). As the KSA MoH begins to vaccinate its general population (Ministry of Health, 2021), it must immediately address any COVID-19 vaccine misinformation among the HCW population to achieve a high vaccination rate among the public. Health care authorities can then empower HCWs to have strong relationships with their patients and prominently feature HCWs in communications campaigns to reduce COVID-19 vaccine misinformation across the KSA.

Strengths & Limitations

The timeliness of this study is crucial as this is the largest study, to our knowledge, evaluating COVID-19 vaccine acceptance and trusted sources of COVID-19 information and organizations in the KSA. However, there are a few limitations that should be considered as well. While our study included a large sample size, and we knew there were approximately 700,000 HCWs registered with the SCHS, we were unable to track the number of emails received, bounced back, and sent to spam. Therefore, we were unable to calculate the response rate. Also, we used a purposive sampling method and not a stratified random sample; thus, our findings may not be generalizable to the whole KSA HCW population. Although almost all HCWs in the KSA have access to a smartphone and/or computer (Altamimi, Khan, & Alex, 2021), the survey was distributed through an online platform, which may limit those who may not have easy access to a smartphone and/or computer. Additionally, our findings were based on HCWs, which may not reflect the general KSA population. Another limitation is that merging the "don't know" and "no" groups may have resulted in some loss of statistical variability when dichotomizing the outcome variable, COVID-19 vaccine acceptance. Lastly, our findings may be influenced by a social desirability bias, as HCWs may respond to the survey questions in a manner that is viewed favorably by others.

Conclusions

Only 64.9% of HCWs would accept a COVID-19 vaccine—with some variability across demographic groups. The main reason reported for COVID-19 vaccine refusal was fear of potential side effects. Our findings highlight the need for KSA health care authorities to frame public health messaging to best address COVID-19 vaccine concerns among the HCW population. After that, HCWs must be empowered to lead communication campaigns to improve COVID-19 vaccine uptake among the general population.
  19 in total

1.  Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence.

Authors:  Wen-Ying Sylvia Chou; Alexandra Budenz
Journal:  Health Commun       Date:  2020-10-30

2.  Determinants of COVID-19 vaccine acceptance in the US.

Authors:  Amyn A Malik; SarahAnn M McFadden; Jad Elharake; Saad B Omer
Journal:  EClinicalMedicine       Date:  2020-08-12

3.  Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey.

Authors:  Mohammed Al-Mohaithef; Bijaya Kumar Padhi
Journal:  J Multidiscip Healthc       Date:  2020-11-20

4.  Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.

Authors:  Jamie Murphy; Frédérique Vallières; Richard P Bentall; Mark Shevlin; Orla McBride; Todd K Hartman; Ryan McKay; Kate Bennett; Liam Mason; Jilly Gibson-Miller; Liat Levita; Anton P Martinez; Thomas V A Stocks; Thanos Karatzias; Philip Hyland
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

5.  COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.

Authors:  Mazin Barry; Mohamad-Hani Temsah; Abdullah Alhuzaimi; Nurah Alamro; Ayman Al-Eyadhy; Fadi Aljamaan; Basema Saddik; Ali Alhaboob; Fahad Alsohime; Khalid Alhasan; Abdulkarim Alrabiaah; Ali Alaraj; Rabih Halwani; Amr Jamal; Sarah Alsubaie; Fatimah S Al-Shahrani; Ziad A Memish; Jaffar A Al-Tawfiq
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

6.  COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.

Authors:  Mazin Barry; Mohamad-Hani Temsah; Fadi Aljamaan; Basema Saddik; Ayman Al-Eyadhy; Shuliweeh Alenezi; Nurah Alamro; Abdullah N Alhuzaimi; Ali Alhaboob; Khalid Alhasan; Fahad Alsohime; Ali Alaraj; Rabih Halwani; Amr Jamal; Omar Temsah; Fahad Alzamil; Ali Somily; Jaffar A Al-Tawfiq
Journal:  Vaccine       Date:  2021-09-02       Impact factor: 3.641

7.  Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia.

Authors:  Rania M Magadmi; Fatemah O Kamel
Journal:  BMC Public Health       Date:  2021-07-21       Impact factor: 3.295

8.  Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia.

Authors:  Harapan Harapan; Abram L Wagner; Amanda Yufika; Wira Winardi; Samsul Anwar; Alex Kurniawan Gan; Abdul Malik Setiawan; Yogambigai Rajamoorthy; Hizir Sofyan; Mudatsir Mudatsir
Journal:  Front Public Health       Date:  2020-07-14

9.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.

Authors:  Hannah Peckham; Nina M de Gruijter; Charles Raine; Anna Radziszewska; Coziana Ciurtin; Lucy R Wedderburn; Elizabeth C Rosser; Kate Webb; Claire T Deakin
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 17.694

View more
  26 in total

1.  Acceptance of COVID-19 Vaccine and Determinant Factors Among Patients with Chronic Disease Visiting Dessie Comprehensive Specialized Hospital, Northeastern Ethiopia.

Authors:  Gete Berihun; Zebader Walle; Leykun Berhanu; Daniel Teshome
Journal:  Patient Prefer Adherence       Date:  2021-08-17       Impact factor: 2.711

2.  SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.

Authors:  Fadi AlJamaan; Mohamad-Hani Temsah; Khalid Alhasan; Shuliweeh Alenezi; Ali Alhaboob; Abdulkarim Alrabiaah; Mohammed Batais; Fatimah Alshahrani; Rasha Asaad Assiri; Hind Bafaqih; Ali Alaraj; Bedoor Al Qadrah; Abdulilah Alhaidary; Khaled Saad; Basema Saddik; Rabih Halwani; Ali A Rabaan; Sarah Al-Subaie; Mazin Barry; Jaffar A Al-Tawfiq
Journal:  J Infect Public Health       Date:  2022-06-17       Impact factor: 7.537

3.  Assessment of COVID-19 Vaccine Acceptance and Reluctance Among Staff Working in Public Healthcare Settings of Saudi Arabia: A Multicenter Study.

Authors:  Muhammad Bilal Maqsood; Md Ashraful Islam; Ali Al Qarni; Zeb-Un- Nisa; Azfar Athar Ishaqui; Naif Khalaf Alharbi; Murtaja Almukhamel; Mohammad Akbar Hossain; Nayyra Fatani; Ahmad Jamal Mahrous; Muhammad Al Arab; Fahad Sami Abdulaziz Alfehaid; Zahida Akbar
Journal:  Front Public Health       Date:  2022-05-30

4.  Using Integrative Behavior Model to Predict COVID-19 Vaccination Intention among Health Care Workers in Indonesia: A Nationwide Survey.

Authors:  Sukamto Koesnoe; Tommy Hariman Siddiq; Dicky C Pelupessy; Evy Yunihastuti; Ghina Shabrina Awanis; Alvina Widhani; Teguh Harjono Karjadi; Suzy Maria; Anshari Saifuddin Hasibuan; Iris Rengganis; Samsuridjal Djauzi
Journal:  Vaccines (Basel)       Date:  2022-05-04

5.  COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.

Authors:  Martin Ackah; Louise Ameyaw; Mohammed Gazali Salifu; Delali Pearl Afi Asubonteng; Cynthia Osei Yeboah; Eugene Narkotey Annor; Eunice Abena Kwartemaa Ankapong; Hosea Boakye
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.752

6.  Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic.

Authors:  Harapan Harapan; Samsul Anwar; Amanda Yufika; Khan Sharun; Mahir Gachabayov; Marhami Fahriani; Milda Husnah; Rawan Raad; Rashed Ya Abdalla; Rashed Y Adam; Namareg Me Khiri; Mohajer Ih Ismaeil; Asma Y Ismail; Wajdi Kacem; Nesrine Bh Dahman; Zeineb Teyeb; Khaoula Aloui; Montacer Hafsi; Manel Ferjani; Dalia A Deeb; Dina Emad; Kirellos Said Abbas; Fatma A Monib; Farah S Sami; R Subramaniam; Suhrud Panchawagh; Sunil Anandu; Md Ariful Haque; Lirane Ed Ferreto; María Fc Briones; Rocío Bi Morales; Sebastián Al Díaz; José To Aburto; Jorge Et Rojas; Emmanuel O Balogun; Seyi S Enitan; Akele R Yomi; Abiodun Durosinmi; Eyiuche D Ezigbo; Esther N Adejumo; Elham Babadi; Edris Kakemam; Najma I Malik; Irfan Ullah; Dott F Rosiello; Talha B Emran; Guilherme W Wendt; Morteza Arab-Zozani; Abram L Wagner; Mudatsir Mudatsir
Journal:  Pathog Glob Health       Date:  2021-12-20       Impact factor: 3.735

7.  Willingness to receive the COVID-19 vaccine and associated factors among residents of Southwestern Ethiopia: A cross-sectional study.

Authors:  Dabala Jabessa; Firomsa Bekele
Journal:  Patient Prefer Adherence       Date:  2022-05-03       Impact factor: 2.314

8.  Impact of Vaccination on the Sense of Security, the Anxiety of COVID-19 and Quality of Life among Polish. A Nationwide Online Survey in Poland.

Authors:  Mateusz Babicki; Wojciech Malchrzak; Anna Hans-Wytrychowska; Agnieszka Mastalerz-Migas
Journal:  Vaccines (Basel)       Date:  2021-12-07

9.  COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.

Authors:  Mazin Barry; Mohamad-Hani Temsah; Abdullah Alhuzaimi; Nurah Alamro; Ayman Al-Eyadhy; Fadi Aljamaan; Basema Saddik; Ali Alhaboob; Fahad Alsohime; Khalid Alhasan; Abdulkarim Alrabiaah; Ali Alaraj; Rabih Halwani; Amr Jamal; Sarah Alsubaie; Fatimah S Al-Shahrani; Ziad A Memish; Jaffar A Al-Tawfiq
Journal:  PLoS One       Date:  2021-11-29       Impact factor: 3.240

10.  COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.

Authors:  Mazin Barry; Mohamad-Hani Temsah; Fadi Aljamaan; Basema Saddik; Ayman Al-Eyadhy; Shuliweeh Alenezi; Nurah Alamro; Abdullah N Alhuzaimi; Ali Alhaboob; Khalid Alhasan; Fahad Alsohime; Ali Alaraj; Rabih Halwani; Amr Jamal; Omar Temsah; Fahad Alzamil; Ali Somily; Jaffar A Al-Tawfiq
Journal:  Vaccine       Date:  2021-09-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.